CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...